Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era

It is clear that existing cardiovascular disease is a major risk factor for COVID-19 and related adverse outcomes. In addition to acute respiratory syndrome, a large cohort also develop myocardial and/or vascular dysfunction, in part from inflammation and renin angiotensin system activation with increased sympathetic outflow, cardiac arrhythmias, ischemia, heart failure, and thromboembolic complications that portend poor COVID-19 outcomes.We summarize here recent information for hospitalists/internists on the front-line of this pandemic regarding its cardiovascular impacts and management and need for cardiovascular consultation.

Source: The American Journal of Medicine - July 8, 2020 Category: General Medicine Authors: Michael R. Massoomi, R. David Anderson, Mustafa M. Ahmed, Osama Dasa, Philip George, William M. Miles, Juan M. Aranda, Carl J. Pepine Tags: Review Source Type: research